Thomas DesRosier

Overview

Thomas DesRosier received an average of $2M in total compensation, including $384K in salary, at Seres Therapeutics from 2016 to 2020.

Related executives

We found six more executives who work or worked at Seres Therapeutics.

David Ege

Seres Therapeutics

Chief Technology Officer

Eric Shaff

Seres Therapeutics

Chief Executive Officer

Matthew Henn

Seres Therapeutics

Chief Scientific Officer

Roger Pomerantz

Seres Therapeutics

Chief Executive Officer

Michele Trucksis

Seres Therapeutics

Chief Medical Officer

Wael Hashad

Seres Therapeutics

Executive Vice President and Chief Commercial Officer

News

You may also like